Pronova, Apotex Strike Deal Over Generic Lovaza
Apotex Corp. on Tuesday agreed to hold off on manufacturing a generic version of Lovaza until 2015 to resolve Norwegian pharmaceutical company Pronova BioPharma Norge AS' patent infringement claims over the...To view the full article, register now.
Already a subscriber? Click here to view full article